Effects of triamcinolone acetonide injected through vitreous cavity on intraocular pressure

SHENG Zhangxing,ZHU Yuefeng
2008-01-01
Abstract:Objective To evaluate the effects of intravitreal triamcinolone acetonide(IVTA) on intraocular pressure(IOP) after the treatment of macular edema. Methods Forty-seven eyes of 47 patients with macular edema due to diabetic retinopathy (DR) or central retinal vein occlusion(CRVO) underwent IVTA with 4mg/0.1ml. Best-corrected visualacuity (BCVA) and IOP were observed before treatment and one month, three months, six months after treatment. Results Of all eyes the average BCVA was (0.15±0.12) before treatment, while one month, three months, and six months after treatment, the average BCVA was (0.36±0.25), (0.39±0.28) and (0.29±0.25) respectively, which had statistical significances compared with that before treatment (t=4.72,4.85,3.21,P<0.05).Meanwhile, Of all eyes IOP was normal ranging 11~18mmHg (13.76±2.18)mmHg before treatment, while one month, three months, and six months after treatment, the average IOP was (18.46±3.87)mmHg,(17.24±4.21)mmHg and (16.34±5.25)mmHg respectively, which had statistical significances compared with that before treatment(t=3.25,3.48,2.51, P<0.05). Some eyes had high IOP temporarily, but IOP could be controlled with topical medicines in all patients during observational period. Conclusion IOP elevation after treatment with IVTA 4mg/0.1ml is existing in a short time. It can be controlled and the treatment was safe and effective.
What problem does this paper attempt to address?